BioXcel Therapeutics (BTAI) Earnings Date, Estimates & Call Transcripts → Have You Seen Elon’s New A.I. Device? (Picture Inside) (From InvestorPlace) (Ad) Free btai Stock Alerts $2.56 +0.02 (+0.79%) (As of 05/2/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 9Before Market OpensConfirmedActual EPS (Mar. 12) -$0.76 Beat By $0.22 Consensus EPS (Mar. 12) -$0.98 Get BioXcel Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for BTAI and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueBTAI Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BTAI Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report BioXcel Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.69)($0.69)($0.69)Q2 20241($0.63)($0.63)($0.63)Q3 20241($0.59)($0.59)($0.59)Q4 20241($0.54)($0.54)($0.54)FY 20244($2.45)($2.45)($2.45)Q1 20251($0.51)($0.51)($0.51)Q2 20251($0.42)($0.42)($0.42)Q3 20251($0.38)($0.38)($0.38)Q4 20251($0.31)($0.31)($0.31)FY 20254($1.62)($1.62)($1.62)BTAI Earnings Date and InformationBioXcel Therapeutics last posted its quarterly earnings data on March 12th, 2024. The reported ($0.76) earnings per share for the quarter, beating analysts' consensus estimates of ($0.98) by $0.22. The company earned $0.38 million during the quarter, compared to the consensus estimate of $1.17 million. BioXcel Therapeutics has generated ($6.15) earnings per share over the last year (($6.15) diluted earnings per share). Earnings for BioXcel Therapeutics are expected to grow in the coming year, from ($2.46) to ($1.85) per share. BioXcel Therapeutics has confirmed that its next quarterly earnings report will be published on Thursday, May 9th, 2024. BioXcel Therapeutics will be holding an earnings conference call on Thursday, May 9th at 8:00 AM Eastern. Interested parties can register for or listen to the call. or dial in at 201-612-7415 with passcode "13745734". Read More BioXcel Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/9/2024Confirmed)------- 3/12/2024Q4 2023($0.98)($0.76)+$0.22($0.76)$1.17 million$0.38 million11/14/2023Q3 2023($1.29)($1.72)($0.43)($1.72)$0.84 million$0.34 million8/14/2023Q2 2023($1.72)($1.83)($0.11)($1.83)$0.42 million$0.46 million 5/8/2023Q1 2023($1.56)($1.84)($0.28)($1.84)$0.50 million$0.21 million 3/9/2023Q4 2022($1.49)($1.95)($0.46)($1.95)$1.08 million$0.24 million 11/10/2022Q3 2022($1.34)($1.49)($0.15)($1.49)$3.05 million$0.14 million Get the Latest News and Ratings for BTAI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioXcel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/9/2022Q2 2022($1.20)($1.35)($0.15)($1.35)-- 5/9/2022Q1 2022($1.21)($1.12)+$0.09($1.12)-- 3/10/2022Q4 2021($1.18)($0.93)+$0.25($0.93)-- 11/9/2021Q3 2021($1.08)($0.96)+$0.12($0.96)-- 8/9/2021Q2 2021($1.03)($1.11)($0.08)($1.11)-- 5/9/2021Q1 2021($0.89)($1.08)($0.19)($1.08)-- BioXcel Therapeutics Earnings - Frequently Asked Questions When is BioXcel Therapeutics's earnings date? BioXcel Therapeutics has confirmed that its next quarterly earnings data will be published on Thursday, May 9th, 2024. Learn more on BTAI's earnings history. Did BioXcel Therapeutics beat their earnings estimates last quarter? In the previous quarter, BioXcel Therapeutics (NASDAQ:BTAI) reported ($0.76) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.98) by $0.22. Learn more on analysts' earnings estimate vs. BTAI's actual earnings. How much revenue does BioXcel Therapeutics generate each year? BioXcel Therapeutics (NASDAQ:BTAI) has a recorded annual revenue of $1.38 million. How much profit does BioXcel Therapeutics generate each year? BioXcel Therapeutics (NASDAQ:BTAI) has a recorded net income of -$179.05 million. BTAI has generated -$6.15 earnings per share over the last four quarters. What is BioXcel Therapeutics's EPS forecast for next year? BioXcel Therapeutics's earnings are expected to grow from ($2.46) per share to ($1.85) per share in the next year. More Earnings Resources from MarketBeat Related Companies: MIST Earnings Results SLS Earnings Results DMAC Earnings Results ALLK Earnings Results PMVP Earnings Results PRPH Earnings Results ABEO Earnings Results GNLX Earnings Results ACRS Earnings Results ORMP Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: PayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting Season This page (NASDAQ:BTAI) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersThe AI stock to buy right nowStockEarningsCould Your Accounts Be Frozen?Allegiance GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithUrgent Nvidia WarningAltimetryBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressNew Trump BombshellThe Freeport SocietyTruth about Trump you’ve never heardPorter & CompanyHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioXcel Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
